The natural anticancer compound rocaglamide selectively inhibits the G1-S-phase transition in cancer cells through the ATM/ATR-mediated Chk1/2 cell cycle checkpoints
Jennifer Neumann, Melanie Boerries, Rebecca Köhler, Marco Giaisi, Peter H Krammer, Hauke Busch, Min Li-Weber
Untersuchen Sie die Forschungsthemen von „The natural anticancer compound rocaglamide selectively inhibits the G1-S-phase transition in cancer cells through the ATM/ATR-mediated Chk1/2 cell cycle checkpoints“. Zusammen bilden sie einen einzigartigen Fingerprint.